MediWound Ltd. (MDWD) stock

MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30

$12.97−0.85 (-6.15%)

Close on Nov 12, 2026Market cap $166.47MP/E –Yield –

MediWound EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

MediWound's EV/EBITDA was 21.6× on Feb 26, 2021.

Period	Period end	Value	Change (pts)
2021	Feb 26, 2021	21.6×	+6.0
2020	Dec 31, 2020	15.6×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MDWD.

Operating margin-149.0% · median -102.0%

Advertisement
300 × 250

See a number that looks wrong?